Cellectis S.A.
EPA:ALCLS.PA
2.065 (EUR) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.755 | 19.171 | 73.949 | 73.949 | 15.19 | 12.731 | 25.188 | 42.584 | 55.043 | 26.299 | 22.816 | 27.815 | 20.728 | 20.98 | 17.319 | 14.77 | 4.101 |
| Cost of Revenue
| 0.737 | 1.772 | 36.275 | 36.275 | 11.392 | 2.739 | 2.62 | 1.688 | 2.706 | 3.691 | 0.848 | 2.03 | 3.26 | 1.922 | 2.325 | 1.542 | 1.477 |
| Gross Profit
| 0.018 | 17.399 | 37.674 | 37.674 | 3.798 | 9.992 | 22.568 | 40.896 | 52.337 | 22.608 | 21.968 | 25.785 | 17.469 | 19.058 | 14.994 | 13.228 | 2.624 |
| Gross Profit Ratio
| 0.024 | 0.908 | 0.509 | 0.509 | 0.25 | 0.785 | 0.896 | 0.96 | 0.951 | 0.86 | 0.963 | 0.927 | 0.843 | 0.908 | 0.866 | 0.896 | 0.64 |
| Reseach & Development Expenses
| 87.646 | 97.501 | 86.95 | 86.95 | 92.042 | 76.567 | 79.227 | 74.565 | 57.3 | 17.519 | 34.44 | 25.102 | 15.95 | 16.373 | 11.42 | 0 | 0 |
| General & Administrative Expenses
| 16.812 | 17.494 | 37.869 | 44.201 | 43.017 | 47.247 | 44.75 | 41.258 | 29.778 | 15.946 | 30.49 | 25.826 | 26.685 | 0 | 7.972 | 5.703 | 4.278 |
| Selling & Marketing Expenses
| 0 | 3.108 | 6.332 | 1.659 | 11.431 | 16.685 | 9.138 | 8.415 | 6.666 | 6.568 | 18.143 | 16.221 | 0 | 17.897 | 15.189 | 0 | 0 |
| SG&A
| 16.812 | 17.494 | 44.201 | 44.201 | 43.017 | 47.248 | 44.75 | 41.258 | 29.779 | 15.946 | 30.49 | 25.826 | 26.685 | 17.897 | 7.972 | 5.703 | 4.278 |
| Other Expenses
| 0 | -7.93 | -8.04 | -8.04 | -7.709 | -8.732 | -8.76 | -10.966 | -4.214 | -4.48 | 2.196 | 0.996 | 0.143 | 0.036 | 19.538 | 12.323 | 0.004 |
| Operating Expenses
| 97.32 | 107.065 | 123.111 | 123.111 | 127.35 | 115.083 | 115.217 | 104.857 | 82.866 | 28.985 | 67.126 | 51.924 | 42.778 | 34.306 | 27.51 | 18.026 | 10.406 |
| Operating Income
| -97.302 | -89.666 | -85.437 | -85.437 | -123.552 | -105.091 | -92.65 | -63.962 | -30.529 | -6.378 | -80.621 | -26.139 | -25.307 | -15.248 | -13.495 | -4.797 | -7.781 |
| Operating Income Ratio
| -128.877 | -4.677 | -1.155 | -1.155 | -8.134 | -8.255 | -3.678 | -1.502 | -0.555 | -0.243 | -3.533 | -0.94 | -1.221 | -0.727 | -0.779 | -0.325 | -1.897 |
| Total Other Income Expenses Net
| -16.352 | -8.935 | -12.046 | -12.046 | 8.34 | 10.507 | -16.549 | 0.599 | 7.141 | 8.549 | -35.916 | -1.735 | 0.174 | 0.487 | -0.979 | 1.115 | 0.004 |
| Income Before Tax
| -116.466 | -98.601 | -97.483 | -97.483 | -115.212 | -88.333 | -103.681 | -63.916 | -22.274 | 2.251 | -81.086 | -27.874 | -25.135 | -14.761 | -11.718 | -3.683 | -6.971 |
| Income Before Tax Ratio
| -154.26 | -5.143 | -1.318 | -1.318 | -7.585 | -6.938 | -4.116 | -1.501 | -0.405 | 0.086 | -3.554 | -1.002 | -1.213 | -0.704 | -0.677 | -0.249 | -1.7 |
| Income Tax Expense
| 0.371 | 0.087 | -11.203 | -24.912 | -24.526 | 16.805 | -13.201 | -1.544 | -0.926 | 2.422 | 4.684 | 1.578 | 5.761 | -4.038 | -6.199 | -3.869 | -2.614 |
| Net Income
| -101.059 | -98.688 | -86.28 | -72.571 | -90.686 | -78.693 | -99.368 | -63.918 | -22.461 | 0.024 | -84.279 | -29.452 | -30.896 | -10.724 | -5.519 | 0.171 | -4.357 |
| Net Income Ratio
| -133.853 | -5.148 | -1.167 | -0.981 | -5.97 | -6.181 | -3.945 | -1.501 | -0.408 | 0.001 | -3.694 | -1.059 | -1.491 | -0.511 | -0.319 | 0.012 | -1.062 |
| EPS
| -1.77 | -2.17 | -1.93 | -1.71 | -2.14 | -1.93 | -2.78 | -1.81 | -0.66 | 0.001 | -4.08 | -1.48 | -2.19 | -0.76 | -0.39 | 0.013 | -0.31 |
| EPS Diluted
| -1.77 | -2.17 | -1.93 | -1.71 | -2.14 | -1.93 | -2.78 | -1.78 | -0.65 | 0.001 | -4.08 | -1.48 | -2.19 | -0.76 | -0.39 | 0.013 | -0.31 |
| EBITDA
| -76.284 | -89.666 | -85.437 | -85.437 | -123.552 | -105.091 | -92.649 | -63.96 | -28.62 | -4.434 | 1.171 | -26.139 | -24.503 | -12.98 | -10.241 | -3.185 | -6.089 |
| EBITDA Ratio
| -101.038 | -4.677 | -1.155 | -1.155 | -8.134 | -8.255 | -3.678 | -1.502 | -0.52 | -0.169 | 0.051 | -0.94 | -1.182 | -0.619 | -0.591 | -0.216 | -1.485 |